The global pericardial disease market is anticipated to grow at a CAGR of around 5.5% during the forecast period (2021-2027). The factors attributing to the growth of the market include the growing geriatric population and rising prevalence of the pericardial disease across the globe. According to United Nations, Department of Economic and Social Affairs report for World Population Ageing 2019, by 2050, 1 in 6 people in the world will be over the age of 65, up from 1 in 11 in 2019. In line with this, there were 703 million persons aged 65 years or over in the world in 2019. The number of older persons is projected to double to 1.5 billion in 2050. Globally, the share of the population aged 65 years or over increased from 6.0% in 1990 to 9.0% in 2019. That proportion is projected to rise further to 16.0% by 2050, so that one in six people in the world will be aged 65 years or over. Though, geriatric populations are more vulnerable to pericardial disease creates demands for advanced treatments, thus higher growth in the market can be seen in upcoming years. Moreover, the rising cardiac diseases are expected to increase the sales for the drugs and treatments associated with the diseases.
To Request a Sample of our Report on Pericardial Disease Market: https://www.omrglobal.com/request-sample/pericardial-disease-market
By geography, Eastern and South-Eastern Asia and Latin America and the Caribbean are the regions with a higher % of the aged population. In Eastern and South-Eastern Asia, the aged population has increased from 6% in 1990 to 11% in 2019, and from 5% to 9% in Latin America and the Caribbean in respective years. Moreover, the developments in the treatments and FDA approvals to the drugs launched by the market players can be expected to further increase the global pericardial diseases market growth.
Market Coverage
· The market number available for – 2020-2027
· Base year- 2020
· Forecast period- 2021-2027
Segment Covered-
· By Application
· By Function
Regions Covered-
· North America
· Europe
· Asia-Pacific
· Rest of the World
· Competitive Landscape- Teva Pharmaceutical Industries Ltd., AstraZeneca PLC, Abbott Laboratories, Edwards Lifesciences Corp, Integra LifeSciences Corp, among others.
(Get 15% Discount on Buying this Report)
A full Report of Pericardial Disease Market is Available at: https://www.omrglobal.com/industry-reports/pericardial-disease-market
Global Pericardial Disease Market Report Segment
By Type
· Acute Pericarditis
· Chronic Pericarditis
· Recurrent Pericarditis
By Diagnosis Method
· Chest X-Ray
· Cardiac MRI
· Cardiac CT Scan
· Echocardiography
· Electrocardiography (EKG)
· Others (Blood Test)
By Treatment Approach
· Nonsteroidal Anti-Inflammatory Agents (NSAIDS) Drugs
· Pericardiectomy
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
